PRELUDE THERAPEUTICS
LIVE

Serial Number

88454849

Owner

Prelude Therapeutics Incorporated

Attorney

Lisa Bollinger Gehman

First Use Date

Apr 20, 2017

Filing Date

May 31, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PRELUDE THERAPEUTICS Trademark

Serial Number: 88454849 • Registration: 6918640

PRELUDE THERAPEUTICS is a trademark filed by Prelude Therapeutics Incorporated on May 31, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Prelude Therapeutics Incorporated (2 trademarks)

200 Powder Mill Road
Wilmington, DE 198032907

Entity Type: 03

Trademark Details

Filing Date

May 31, 2019

Registration Date

December 6, 2022

First Use Anywhere

April 20, 2017

First Use in Commerce

April 20, 2017

Published for Opposition

March 15, 2022

Goods & Services

Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 1, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 31, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 12, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 12, 2022 AITU
USE AMENDMENT FILED
Sep 29, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 29, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 10, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2022 NONP
ASSIGNED TO LIE
Feb 6, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 2, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 18, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 18, 2021 GNFR
FINAL REFUSAL WRITTEN
Aug 18, 2021 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 24, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 20, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 20, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 20, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 23, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 23, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 23, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2019 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 24, 2019 TCCA
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2019 NWOS
NEW APPLICATION ENTERED
Jun 4, 2019 NWAP